Pharmaceutical Benefits Regulations (Amendment) (Cth)
STATUTORY RULES.
REGULATIONS UNDER THE PHARMACEUTICAL BENEFITS ACT 1947-1952.*
I, THE GOVERNOR-GENERAL in and over the Commonwealth
of Australia, acting with the advice of the Federal Executive Council, hereby
make the following Regulations under the
Dated this fifth day of March, 1954.
W. J. Slim
Governor-General.
By His Excellency’s Command,
Minister of State for Health.
Amendments of the Pharmaceutical Benefits Regulations.
(
a ) pharmaceutical benefits supplied on presentation of prescriptions written on or after the first day of February, 1954; and(
b ) where, in the case of prescriptions written before that date, pharmaceutical benefits are supplied on presentation of those prescriptions for a second or subsequent time on or after that date—pharmaceutical benefits so supplied.
* Notified in the
Statutory Rules 1950, No. 48, as amended by Statutory Rules 1950, Nos. 51, 55, 62 and 94; 1951, Nos. 15, 89 and 135; 1952, No. 22; and 1953, Nos. 40, 57, 78 and 100.
265.—Price 5d. 9/26.1.1954.
THE SCHEDULES.
First Schedule.
Regulation 1.
AMENDMENTS OF THE SECOND SCHEDULE TO THE PHARMACEUTICAL BENEFITS REGULATIONS.
| |||||
|
|
|
|
|
|
| |||||
|
|
|
|
|
|
|
|
|
| ||
|
|
|
| ||
|
|
|
| ||
|
|
|
| ||
|
|
|
| ||
| |||||
|
|
|
|
|
|
|
|
|
| ||
| |||||
|
|
|
|
|
|
|
|
|
| ||
| |||||
|
|
|
|
|
|
|
|
|
| ||
|
|
|
| ||
| |||||
| Diphtheria Toxoid Purified (diluted for skin test only) |
|
|
|
|
| |||||
|
|
|
|
|
|
|
|
|
| ||
|
|
|
| ||
|
|
|
| ||
|
|
|
| ||
| |||||
|
|
|
|
|
|
| |||||
|
|
|
|
|
|
|
|
|
| ||
|
|
|
| ||
|
|
|
| ||
|
|
|
| ||
|
|
|
| ||
|
|
|
| ||
The Schedules—
“80a | Hartmann’s Solution | .............................. | 1 litre bottle........... | 2 | 1 |
“80b | Hartmann’s Solution with Dextrose | 5%........................ . | 1 litre bottle........... | 2 | 1 |
10%...................... | 1 litre bottle........... | 2 | 1”. | ||
10. Insert after item 91 the following item:— | |||||
“91a | Insulin, Isophane, Injection of | 40 U. per cc........... | 5 cc. vial................ | 3 | 12 |
40 U. per cc........... | 10 cc. vial.............. | 3 | 12 | ||
80 U. per cc........... | 10 cc. vial.............. | 3 | 12”. | ||
11. Omit item 94, insert in its stead the following item:— | |||||
“94 | Isoniazid.............. | .............................. | 50 mg. tab.............. | 100 | 1”. |
12. Omit item 101, insert in its stead the following item:— | |||||
“101 | Liver Extract, Injection of | 2 U.S.P. U. per cc. | 1 cc. amp............... | 6 | 1 |
2 U.S.P. U. per cc. | 10 cc. vial.............. | 6 | 1 | ||
5 U.S.P. U. per cc. | 2 cc. vial................ | 6 | 1 | ||
5 U.S.P. U. per cc. | 10 cc. vial.............. | 1 | 1 | ||
5 U.S.P. U. per cc. | 20 cc. vial.............. | 1 | 1 | ||
10 U.S.P. U. per cc. | 10 cc. vial.............. | 1 | 1 | ||
15 U.S.P. U. per cc. | 5 cc. vial................ | 1 | 1”. | ||
13. Omit item 107, insert in its stead the following item:— | |||||
“107 | Mercuramide with Theophylline, Injection of | .............................. | 1 cc. amp............... | 10 | .. |
.............................. | 2 cc. amp............... | 10 | ..”. | ||
14. Insert after item 133 the following item:— | |||||
“133a | Pancreatin...................... | .............................. | 5 gr. tab................. | 100 | ..”. |
15. Insert after item 136 the following item:— | |||||
“136a | Paramethadione............. | .............................. | 0.3 G. cap.............. | 100 | 2”. |
16. Omit items 139, 140 and 141, insert in their stead the following items:— | |||||
“139 | Penicillin, Injection of | .............................. | 5,000 U. amp. | 6 | .. |
.............................. | 15,000 U. amp. | 6 | .. | ||
.............................. | 100,000 U. amp. | 6 | .. | ||
.............................. | 200,000 U. amp. | 6 | .. | ||
.............................. | 500,000 U. amp. | 6 | .. | ||
.............................. | 1,000,000 U. amp. | 6 | .. | ||
.............................. | 2,000,000 U. amp. | 6 | .. | ||
“140 | Penicillin, Procaine, Aqueous Suspension of | .............................. | 300,000 U. vial | 6 | .. |
.............................. | 400,000 U. vial | 6 | .. | ||
.............................. | 600,000 U. vial | 6 | .. | ||
.............................. | 900,000 U. vial | 6 | .. | ||
.............................. | 1,000,000 U. vial | 6 | .. | ||
.............................. | 3,000,000 U. vial | 6 | .. | ||
400,000 U. per cc. | 10 cc. vial............... | 6 | .. | ||
The Schedules—
“141 | Penicillin, Procaine (Crystalline), Injection of | .............................. | 300,000 U. amp. | 6 | .. |
.............................. | 400,000 U. amp. | 6 | .. | ||
.............................. | 500,000 U. amp. | 6 | .. | ||
.............................. | 600,000 U. amp. | 6 | .. | ||
.............................. | 667,000 U. amp. | 6 | .. | ||
.............................. | 900,000 U. amp. | 6 | .. | ||
.............................. | 1,200,000 U. amp. | 6 | .. | ||
.............................. | 1,500,000 U. amp. | 6 | .. | ||
.............................. | 2,000,000 U. amp. | 6 | .. | ||
.............................. | 3,000,000 U. amp. | 6 | .. | ||
.............................. | 4,000,000 U. amp. | 6 | ..”. | ||
17. Omit item 146, insert in its stead the following item:— | |||||
“146 | Pertussis Vaccine (Phase 1) | 1,000 M. per cc. | 1 cc. amp............... | 3 | 1 |
5,000 M. per cc. | 1 cc. amp............... | 3 | 1 | ||
5,000 M. per cc. | 10 cc. vial.............. | 1 | .. | ||
10,000 M. per cc. | 1 cc. amp............... | 3 | 1 | ||
10,000 M. per cc. | 10 cc. vial.............. | 1 | .. | ||
20,000 M. per cc. | 1 cc. amp. ............. | 3 | 1 | ||
20,000 M. per cc. | 10 cc. vial.............. | 1 | .. | ||
50,000 M. per cc. | 5 cc. vial................ | 1 | .. | ||
60,000 M. per 1.5 cc. | 1.5 cc. vial............. | 1 | .. | ||
.............................. | set of 3 amps. containing 50,000 M. per set | 1 | ..”. | ||
18. Insert after item 152 the following item:— | |||||
“152a | Phenylindanedione........ | .............................. | 50 mg. tab.............. | 50 | ..”. |
19. Omit item 155, insert in its stead the following item:— | |||||
“155 | Phthalylsulphathiazole | .............................. | 0.5 G. tab............... | 100 | 1”. |
20. Insert after item 160 the following item:— | |||||
“160a | Primidone......................... | .............................. | 0.25 G. tab............. | 100 | 2”. |
21. Omit item 162, insert in its stead the following items:— | |||||
“161a | Procyclidine Hydrochloride | .............................. | 5 mg. tab................ | 100 | 1 |
“162 | Progesterone, Injection of | .............................. | 5 mg. amp.............. | 6 | .. |
.............................. | 10 mg. amp............ | 6 | .. | ||
.............................. | 20 mg. I.V. amp..... | 3 | ..”. | ||
22. Omit item 184, insert in its stead the following item:— | |||||
“184 | Stilboestrol.................... | .............................. | 1 mg. amp.............. | 6 | .. |
.............................. | 5 mg. amp.............. | 6 | .. | ||
.............................. | 1 mg. tab................ | 100 | 1 | ||
.............................. | 5 mg. tab................ | 100 | 1 | ||
.............................. | 10 mg. tab.............. | 100 | 1”. | ||
The Schedules—
23. Omit items 186, 187, 188 and 189, insert in their stead the following items:— | |||||
“186 | Succinylsulphathiazole | .............................. | 0.5 G. tab............... | 100 | 1 |
“187 | Sulphacetamide.............. | .............................. | 0.5 G. tab............... | 50 | .. |
“188 | Sulphadiazine................. | .............................. | 0.3 G. tab............... | 50 | .. |
.............................. | 0.5 G. tab............... | 50 | .. | ||
“189 | Sulphadimidine............... | .............................. | 0.25 G. tab............. | 50 | .. |
.............................. | 0.5 G. tab............... | 50 | ..”. | ||
24. Omit items 191 and 192, insert in their stead the following items:— | |||||
“191 | Sulphaguanidine............ | .............................. | 0.5 G. tab............... | 100 | 1 |
“192 | Sulphamerazine.............. | .............................. | 0.5 G. tab............... | 50 | ..”. |
25. Insert after item 193 the following item:— | |||||
“193a | Sulphapyridine............... | .............................. | 0.125 G. tab........... | 50 | .. |
.............................. | 0.5 G. tab............... | 50 | ..”. | ||
26. Omit item 195, insert in its stead the following item:— | |||||
“195 | Sulphathiazole.............. | .............................. | 0.3 G. cap.............. | 50 | .. |
.............................. | 0.5 G. tab............... | 50 | ..”. | ||
27. Insert after item 201 the following items:— | |||||
“201a | Terramycin Oral Suspension | 0.25 G. per 5 cc. | 1 fl. oz. bottle | 1 | .. |
“201b | Testosterone.................. | .............................. | 100 mg. implant | 1 | .. |
.............................. | 150 mg. implant | 1 | .. | ||
.............................. | 200 mg. implant | 1 | ..”. | ||
28. Omit item 203, insert in its stead the following items:— | |||||
“202a | Testosterone Oenanthate, Injection of | 250 mg. per cc....... | 1 cc. amp............... | 1 | .. |
“202b | Testosterone Phenyl Propionate, Injection of | 50 mg. per cc......... | 1 cc. amp............... | 3 | .. |
50 mg. per cc......... | 5 cc. vial................ | 1 | .. | ||
“203 | Testosterone Propionate, Injection of | 25 mg. per cc......... | 1 cc. amp............... | 12 | .. |
50 mg. per cc......... | 1 cc. amp............... | 12 | .. | ||
50 mg. per cc......... | 10 cc. vial.............. | 1 | .. | ||
100 mg. per 2 mil... | 2 mil. amp............. | 1 | .. | ||
.............................. | 100 mg. implant | 1 | ..”. | ||
29. Omit item 215, insert in its stead the following item:— | |||||
“215 | Vitamin B 12, Injection of | 10 γ per cc............. | 1 cc. amp............... | 12 | 1 |
15 γ per cc............. | 1 cc. amp............... | 12 | 1 | ||
20 γ per cc............. | 1 cc. amp............... | 12 | 1 | ||
50 γ per cc............. | 1 cc. amp............... | 6 | 1 | ||
100 γ per cc........... | 1 cc. amp............... | 1 | 1 | ||
1,000 γ per cc........ | 1 cc. amp............... | 1 | .. | ||
1,000 γ per cc........ | 10 cc. vial.............. | 1 | ..”. | ||
30. Omit item 218, insert in its stead the following item:— | |||||
“218 | Vitamin K (Oral).............. | .............................. | 1 mg. cap............... | 100 | 1 |
.............................. | 4 mg. cap............... | 100 | 1 | ||
.............................. | 1 mg. tab................ . | 100 | 1 | ||
.............................. | 4.8 mg. tab............. . | 100 | 1 | ||
.............................. | 5 mg. tab................ | 100 | 1 | ||
.............................. | 10 mg. tab.............. | 100 | 1”. | ||
The Schedules—
Second Schedule.
Regulation 2.
AMENDMENTS OF THE THIRD SCHEDULE TO THE PHARMACEUTICAL BENEFITS REGULATIONS.
1. Omit paragraph (
“(
2. Insert after paragraph 6 the following paragraph:—
“7. Where an approved pharmaceutical chemist who supplies a pharmaceutical benefit issues a repeat authorization for the further supply of that pharmaceutical benefit under sub-regulation (4.) of regulation 17 of these Regulations, the amount of payment which would otherwise be payable in respect of that pharmaceutical benefit shall be increased by Fourpence.”.
By Authority: L. F. Johnston, Commonwealth Government Printer, Canberra.
0
0
0